UAB "Natural Pharmaceuticals" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
2,968,983 |
1,484,492 |
-134,954 |
-139,125 |
-69,563 |
71.23 |
-4.69 |
683,175 |
383,073 |
36,803 |
1,030,368 |
2023 |
---|
2,564,858 |
1,899,895 |
50,420 |
35,631 |
26,393 |
79.48 |
1.39 |
718,806 |
290,399 |
31,085 |
970,912 |
2024 |
---|
2,211,061 |
2,211,061 |
128,841 |
106,135 |
106,135 |
81.69 |
4.80 |
824,941 |
226,018 |
18,820 |
1,025,352 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
2,211,061 €-14 % *
Sales per employee (€)
2,211,061 €16 % *
Profit before tax (€)
128,841 €156 % *
Net Profit (€)
106,135 €198 % *
Profit per employee (€)
106,135 €302 % *
Total profitability (%)
81.69 %2.78 % *
Net profitability (%)
4.80 %245.32 % *
Equity (€)
824,941 €15 % *
Amounts Payable And Liabilities (€)
226,018 €-22 % *
Non-current Assets (€)
18,820 €-39 % *
CurrentAssets (€)
1,025,352 €6 % *